NCT01881048 2026-01-29Window of Opportunity Study Targeting the Inflammatory MilieuUniversity of Colorado, DenverPhase EARLY_PHASE1 Completed42 enrolled
NCT03599453 2023-07-18Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast CancerRoswell Park Cancer InstitutePhase EARLY_PHASE1 Completed8 enrolled